Control of multidrug resistant tuberculosis. DOTS-plus strategy will be hard to implement.
作者信息
Ollé-Goig J E
出版信息
BMJ. 1999 Mar 13;318(7185):736. doi: 10.1136/bmj.318.7185.736b.
Abstract
摘要
相似文献
1
Control of multidrug resistant tuberculosis. DOTS-plus strategy will be hard to implement.耐多药结核病的控制。直接督导下的短程化疗强化策略将难以实施。
BMJ. 1999 Mar 13;318(7185):736. doi: 10.1136/bmj.318.7185.736b.
2
[Establishing DOTS-Plus strategy for control of multi-drug resistant tuberculosis].[建立用于控制耐多药结核病的强化期直接督导下的短程化疗策略]
Zhonghua Jie He He Hu Xi Za Zhi. 2006 Aug;29(8):507-8.
3
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis.直接观察治疗短程化疗（DOTS）与强化版直接观察治疗短程化疗（DOTS-plus）对耐多药结核病及结核病死亡的影响：决策分析
BMJ. 2003 Mar 15;326(7389):574. doi: 10.1136/bmj.326.7389.574.
4
DOTS plus strategy in resource-poor countries.
Int J Tuberc Lung Dis. 1999 Sep;3(9):843; author reply 844.
5
Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.台湾实施直接观察治疗短程化疗(DOTS)和 DOTS-Plus 方案后，获得性耐多药结核病发病率下降。
J Antimicrob Chemother. 2013 Aug;68(8):1910-6. doi: 10.1093/jac/dkt103. Epub 2013 Apr 10.
6
DOTS and DOTS-Plus: what's in a name.
Int J Tuberc Lung Dis. 2000 Nov;4(11):995-6.
7
Slow elimination of multidrug-resistant tuberculosis.耐多药结核病的缓慢清除。
Sci Transl Med. 2009 Oct 21;1(3):3ra8. doi: 10.1126/scitranslmed.3000346.
8
Can DOTS control multidrug-resistant tuberculosis?直接观察治疗短程化疗能否控制耐多药结核病？
Lancet. 2005;365(9466):1206-9. doi: 10.1016/S0140-6736(05)74788-7.
9
MDR-TB and the developing world--a problem no longer to be ignored: the WHO announces 'DOTS Plus' strategy.耐多药结核病与发展中世界——一个不容忽视的问题：世界卫生组织宣布“强化直接督导短程化疗”战略
Int J Tuberc Lung Dis. 1998 Nov;2(11):867.
10
Drug resistant tuberculosis can be controlled, says WHO.世界卫生组织称，耐药结核病可得到控制。
BMJ. 2000 Mar 25;320(7238):821.
引用本文的文献
1
Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.弥合政策与实践之间的差距：对埃塞俄比亚亚的斯亚贝巴耐多药结核病患者直接观察治疗中提供者现场经验的定性分析。
BMJ Open. 2020 Jun 16;10(6):e035272. doi: 10.1136/bmjopen-2019-035272.
本文引用的文献
1
Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus".基于社区的耐多药结核病控制方法：引入“强化直接观察治疗策略”。
BMJ. 1998 Sep 5;317(7159):671-4. doi: 10.1136/bmj.317.7159.671.
2
Non-compliance with tuberculosis treatment: patients and physicians.结核病治疗的不依从性：患者与医生
Tuber Lung Dis. 1995 Jun;76(3):277-8. doi: 10.1016/s0962-8479(05)80022-x.
Zotero 插件